Head to Head Survey: Retractable Technologies (NYSE:RVP) & Check-Cap (NASDAQ:MBAI)

Check-Cap (NASDAQ:MBAI – Get Free Report) and Retractable Technologies (NYSE:RVP – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Volatility and Risk

Check-Cap has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500.

Get Check-Cap alerts:

Analyst Recommendations

This is a summary of current ratings and recommmendations for Check-Cap and Retractable Technologies, as reported by MarketBeat.com.

Insider and Institutional Ownership

1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Check-Cap and Retractable Technologies”s top-line revenue, earnings per share (EPS) and valuation.

Check-Cap has higher earnings, but lower revenue than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Check-Cap and Retractable Technologies’ net margins, return on equity and return on assets.

Summary

Check-Cap beats Retractable Technologies on 6 of the 11 factors compared between the two stocks.

About Check-Cap

(Get Free Report)

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.